Study showed that although non-alcoholic fatty liver disease (NAFLD) was the first cause of liver enzyme abnormalities, reduced ALT has been strongly associated with sarcopenia (36). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.